Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Solicits Protocol For Assessing Cosmetic Ingredient Aggregate Exposure Risks
Jun 06 2019
•
By
Ryan Nelson
More from Ingredients & Safety
More from HBW Insight